Founded with a mission to advance personalized medicine, KEW Group, Inc. specializes in DNA-based genomic testing and interpretation services. The company provides a web-based platform, primarily targeting oncology practitioners and other healthcare professionals, to deliver comprehensive information about current and emerging therapies. Their flagship product, CANCERPLEX, offers extensive genomic profiling and immunotherapy analytics to support precision medicine in oncology.
KEW Group has garnered attention for its innovative approach to personalized healthcare, collaborating with leading molecular labs to enhance oncology precision medicine programs. Notable affiliations include partnerships with prominent healthcare institutions and contributions from experts in genomics and oncology. The company’s key achievements include the successful deployment of their genomic profiling solutions, significantly impacting treatment decisions and patient care quality in the field of oncology.
